Latest Papilloma Stories
Every year in the United States, about 37,000 new patients are diagnosed with oral cancer "“ that's about the same as the population of Del Rio. And there are about 8,000 fatalities a year "“ more than the entire population of Alamo Heights. In fact, within five years of diagnosis, almost half of the patients will be dead. In recognition of National Oral Cancer Awareness Month (April), San Antonio cosmetic dentist Dr. Edward Camacho, DDS, and his Cosmetic Dentistry of San Antonio...
(Ivanhoe Newswire) --Oral Sex. It's been linked to oral, head and neck cancer, but a new report shows it may be causing more throat cancer than tobacco.HPV (or human papillomavirus) is a virus passed on through oral sex. Researchers studying the virus say that HPV causes 64 percent of oropharynxl cancers in the U.S. Scientists say HPV is now thought to be the main cause of throat cancer in people under 50 years old.The study was presented at the American Association for the Advancement of...
BLUE BELL, Pa., Mar. 7, 2011 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE Amex: INO), a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that it is initiating a Phase II clinical trial for its VGX-3100 DNA vaccine for cervical dysplasia and cancer caused by human papillomavirus (HPV). The study will assess adult females with CIN 2/3 or CIN 3 and biopsy-proven HPV 16 or 18. Cervical intraepithelial neoplasias...
U.S. researchers said on Monday that half of the men in the general population may be infected with human papillomavirus or HPV, the virus that causes cervical and other cancers. U.S. vaccine advisers have been weighing whether boys and young men should be vaccinated against the human papillomavirus, but some worry the vaccine is too costly to justify its use. HPV infection is know best for causing cervical cancer, which is the second most common cancer in women around the world. However,...
SAN ANTONIO, Feb. 28, 2011 /PRNewswire/ -- Advanced Cell Diagnostics, Inc. (ACD) today announced the results of its clinical study utilizing RNAscope(TM) technology to detect human papillomavirus (HPV) E6/E7 mRNA in routine clinical specimens of head and neck cancer. HPV status determined by the RNAscope(TM) HPV test was highly predictive of patient outcome and highly concordant with that determined by existing methods. Significantly, the RNAscope(TM) test under development demonstrated 16%...
ATHENA study shows the cobas HPV Test advances the standard of care by providing valuable information on the risks associated with the genotypes which cause 70 percent of cervical cancer PLEASANTON, Calif., Feb. 24, 2011 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that a study published online today in the American Journal of Clinical Pathology demonstrated the ability of the cobas HPV Test to individually detect HPV-16 and HPV-18, two of the highest risk HPV genotypes...
By Kristen Bole, UCSFThe vaccine for human papillomavirus (HPV) can prevent 90 percent of genital warts in men when offered before exposure to the four HPV strains covered by the vaccine, according to a new multi-center study led by H. Lee Moffitt Cancer Center and UCSF. The four-year, international clinical trial, which also found a nearly 66 percent effectiveness in the general population of young men regardless of prior exposure to these strains, provides the first reported results of...
(Ivanhoe Newswire) -- Infection with human papillomavirus (HPV) and diseases caused by HPV are common in boys and men.  A new report shows the safety of a quadrivalent vaccine and on its efficacy in preventing the development of external genital lesions and anogenital HPV infection in boys and men.Study authors enrolled 4065 healthy boys and men 16 to 26 years of age, from 18 countries in a randomized, placebo-controlled, double-blind trial. The primary efficacy objective was to show...
Indulgent chocolate treats may be the best-known and most widely appreciated product of the cacao tree, but new scientific research from New York Based Cacao Biotechnologies is uncovering potential new applications for the antioxidant-rich beans which could spur an innovative approach to treating human papillomavirus (HPV), a precursor to cervical cancer. Brooklyn, NY (PRWEB) January 24, 2011 Indulgent chocolate treats may be the best-known and most widely appreciated product of the...
CHAPEL HILL, N.C., Jan. 20, 2011 /PRNewswire/ -- As our country observes National Cervical Cancer Awareness Month in January, a growing number of public health experts are working to stamp out this preventable disease - state by state - once and for all. The Cervical Cancer-Free America (CCFA) initiative, led by the University of North Carolina at Chapel Hill's Gillings School of Global Public Health, announced today that six states have already joined its multi-state, multi-year effort to...
Latest Papilloma Reference Libraries
A human papillomavirus (HPV), a member of the papillomavirus family, is capable of infecting humans. HPVs establish productive infections in the skin or mucous membranes. Most of the 200 known types cause no symptoms in most people. Some types can cause warts, while others can lead to cancer. There are more than 30 to 40 types of HPV that are typically transmitted through sexual contact and infect the anogenital region. High risk HPV, can lead to cancer, in fact HPV infection is a cause of...
Bovine papillomavirus (BPV), of the Papillomaviridae family, is a group of DNA viruses common in cattle. The virus can cause warts of the skin and alimentary tract and in rare cases cancer. It is also though that equine sarcoid, a skin tumor, is brought on in horses and donkeys by BPV. BPV is a good model for the study of the papillomavirus molecular biology. Like others in their family BPVs are small non-enveloped viruses with an icosahedral capsid around 50-60 nm in diameter. BPVs have...
